C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on targeted protein degradation, a drug-development approach designed to eliminate disease-causing proteins rather than only blocking their activity. The company develops small-molecule medicines built on its proprietary TORPEDO platform, which is used to design and optimize degraders for difficult-to-treat diseases. Its current pipeline is centered on oncology, with programs aimed at cancers such as multiple myeloma, lymphoma, melanoma, colorectal cancer, and non-small cell lung cancer. C4 Therapeutics also works through strategic collaborations with other biopharmaceutical companies to expand the reach of its technology and advance new therapeutic candidates. Based in Watertown, Massachusetts, C4 Therapeutics plays a specialized role in the biotechnology market by advancing a next-generation therapeutic modality that seeks to address targets and pathways not readily handled by traditional small-molecule drugs.
Website490 Arsenal Way
Watertown, MA, 02472
United States
Here is how C4 Therapeutics, Inc. (CCCC) and MacroGenics (MGNX) have performed compared to their sector so far this year.
Does C4 Therapeutics, Inc. (CCCC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Detailed price information for C4 Therapeutics Inc (CCCC-Q) from The Globe and Mail including charting and trades.
Investors talking about CCCC also mention
What share of all stock conversation is about CCCC?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% +0 | 0% +0 | 0% 0 |
Of the messages about CCCC that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 97.06% -2.94 | 98.89% +20.32 | 73.36% -6.93 | ||
| Bearish | 0% | 2.94% new | 1.11% -20.32 | 26.64% +6.93 |
Of the messages about CCCC that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 0% | 71.43% | 92.12% | 62.87% | ||
| Technical Analysis | 100% | 28.57% | 2.42% | 32.42% | ||
| Earnings | 0% | 0% | 0% | 0.47% | ||
| Macro | 0% | 0% | 5.45% | 2.26% | ||
| Analysts | 0% | 0% | 0% | 1.7% | ||
| Controversies | 0% | 0% | 0% | 0.28% |
Of the messages about CCCC, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 31.91% | 35.9% | 55.89% | 48.84% | ||
| Newcomers | 68.09% | 64.1% | 44.11% | 51.16% |